Form 4: Evolv Director Sells Shares After Option Exercise

Evolv Technologies Director Michael Ellenbogen exercised stock options and subsequently sold 80,745 shares of Class A Common Stock for a weighted average price of $8.26 per share.

Summary

• Michael Ellenbogen, a Director and 10% Owner of Evolv Technologies Holdings, Inc. (EVLV), reported transactions on October 15, 2025.
• Ellenbogen exercised stock options to acquire 80,745 shares of Class A Common Stock at an exercise price of $0.24 per share.
• Concurrently, he sold 80,745 shares of Class A Common Stock at a weighted average price of $8.26 per share. The sales occurred in multiple transactions ranging from $8.03 to $8.54.
• These sales were executed pursuant to a Rule 10b5-1 trading plan established on June 12, 2025.
• Following these transactions, Ellenbogen directly holds 2,083,961 shares of Class A Common Stock and indirectly holds 151,135 shares through the Family Horizon Trust.
• He also retains 1,542,974 stock options (right to buy) with an exercise price of $0.24, which vested starting January 31, 2018.

Sentiment

Score: 6

Explanation: The exercise of options and subsequent sale is a routine insider transaction, often for liquidity or diversification. The pre-planned nature (10b5-1) mitigates negative sentiment, but any insider selling can be viewed with slight caution. The significant profit from option exercise is a positive for the insider.

Positives

• The exercise of stock options indicates that the director saw value in acquiring shares at the exercise price of $0.24.
• The sale price of $8.26 per share represents a significant gain over the exercise price, demonstrating value creation for the option holder.

Negatives

• The sale of 80,745 shares by a director and 10% owner could be perceived negatively by some investors, as it reduces direct insider ownership.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: May observe a reduction in direct insider ownership, though the pre-planned nature (10b5-1) suggests it is for personal financial management rather than a reaction to new negative company information. The transaction highlights the value realized by an insider.

Key Dates

Recommendation

A Form 4 filing detailing an insider's exercise of options and subsequent sale, especially when executed under a Rule 10b5-1 plan, typically does not provide sufficient new information to warrant a change in investment recommendation. While insider selling can sometimes be a bearish signal, the pre-planned nature suggests it is for personal financial management rather than a reaction to new company-specific negative news. Investors should consider this as a routine liquidity event for the director rather than a fundamental shift in the company's prospects, thus maintaining a 'hold' position based solely on this filing.

Keywords

Evolv Technologies, EVLV, Michael Ellenbogen, Insider Trading, Form 4, Stock Option Exercise, Share Sale, 10b5-1 Plan, Director Transaction, Beneficial Ownership